Ukraine as a Partner for Military Medical Innovation: Development, Evidence and Adoption
Since 2022, Ukrainian clinicians have treated casualties of high-intensity combat under the conditions U.S. and NATO forces must plan for: delayed evacuation, casualty surges, complex injuries, and prolonged recovery. Svitlana Malovana, President and Co-Founder of the Ukrainian-American MedTech Association (UAMTA), will show members working on combat trauma, surgery, rehabilitation, and mental health how to use that experience to test products against the requirements of modern warfare, generate credible evidence, and strengthen their offer to military customers.
The session runs in three parts:
- Why Ukraine and how to build a collaboration. What Ukraine offers, how to choose a partner and organize the work, how to handle data, ethics review, and approvals, and how to plan budget and wartime logistics.
- Evidence that supports adoption and sales. How results from Ukraine can show clinical value, usability, and performance to U.S. and NATO customers, and when additional validation is needed.
- Guest conversation. An organization already working with Ukrainian partners shares practical lessons: how they started, what worked, and what to watch for.
Members should leave with a clear answer to the question “Why Ukraine for our solution?”, a practical collaboration format and the basis for a project brief, and an understanding of how evidence from Ukraine can strengthen their offer to military customers and where its limits are.
UAMTA is a U.S.-registered nonprofit in New York that connects U.S. medical technology developers with Ukraine’s military medicine, clinical, research, and rehabilitation communities. It helps partners find the right Ukrainian collaborators and structure joint development and evidence projects. Svitlana is a Ukrainian lawyer and entrepreneur based in New York whose work spans device commercialization, FDA regulatory pathways, clinical research partnerships, and technology transfer. Forty minutes of content followed by twenty minutes of discussion and Q&A.
Registration – https://us06web.zoom.us/meeting/register/ZiLL-Ey4SSWzpL_QAp_fDA